Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

5.27
-0.2200-4.01%
Pre-market: 5.24-0.0300-0.57%04:05 EDT
Volume:1.35M
Turnover:7.12M
Market Cap:101.93M
PE:-0.87
High:5.80
Open:5.80
Low:5.13
Close:5.49
52wk High:20.56
52wk Low:5.13
Shares:19.34M
Float Shares:13.25M
Volume Ratio:1.54
T/O Rate:10.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.00
PE(LYR):-0.89

Loading ...

Corbus Pharmaceuticals Q2 EPS $(1.81) Misses $(1.26) Estimate

Benzinga Earnings
·
Aug 06

Corbus Q2 FY26 Net Loss Widens to $35.04 Million; Loss Per Share Increases to $1.81

Reuters
·
Aug 06

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 05

Corbus Pharma CMO Nicacio Leonardo Viana Files Initial Beneficial Ownership Statement

Reuters
·
Aug 05

Corbus reports last patient completes last visit in CANYON-1 trial

TIPRANKS
·
Aug 04

Corbus Says Phase 1b Canyon-1 Obesity Trial of CRB-913 Reaches Last Patient Last Visit

Reuters
·
Aug 04

Corbus Pharmaceuticals Announces Last Patient Last Visit in Canyon-1 Study of Crb-913 for the Treatment of Obesity

THOMSON REUTERS
·
Aug 04

Corbus Pharmaceuticals Holdings Inc Expected to Post a Loss of $1.26 a Share - Earnings Preview

Reuters
·
Jul 31

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 30

Corbus Pharmaceuticals announces FDA clearance to initiate TEMPO-1 trial

TIPRANKS
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate Tempo-1 Registrational Study of Crb-701 in Patients with 2L Oropharyngeal Cancer

THOMSON REUTERS
·
Jul 28

Corbus Pharmaceuticals Holdings Inc: Expects to Initiate Enrollment in Tempo-1 in September 2026

THOMSON REUTERS
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

GlobeNewswire
·
Jul 28

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 23

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 21

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 18

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 17